Product Information
Registration Status: ActiveSIN15479P
ADACEL-POLIO SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE is approved to be sold in Singapore with effective from 2018-05-08. It is marketed by SANOFI-AVENTIS SINGAPORE PTE LTD, with the registration number of SIN15479P.
This product contains Filamentous Haemagglutinin 5 µg/ 0.5 ml,Fimbriae Type 2 And 3 5 µg/0.5 ml,Pertactin 3 µg/0.5 ml,Pertussis Toxoid 2.5 µg/ 0.5 ml,Diphtheria Toxoid 2Lf,Poliomyelitis VaccineType 1 40 D-Antigen Units,Poliomyelitis Vaccine Type 2 8 D-antigen units,Poliomyelitis Vaccine Type 3 32 D-antigen units, and Tetanus Toxoid 5Lf in the form of INJECTION, SUSPENSION. It is approved for INTRAMUSCULAR use.
This product is manufactured by Sanofi Pasteur (VDR) in CANADA, andSANOFI PASTEUR LIMITED in FRANCE.
It is a Prescription Only Medicine that can only be obtained from a doctor or a dentist, or a pharmacist with a prescription from a Singapore-registered doctor or dentist.
Product Reference
Important Note: For generic product, the SPC/PIL provided may not be brand specific.
{{/items}} {{^items}}Description
Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) is a vaccine that contains inactivated acellular pertussis antigen that is isolated from Bordetella pertussis culture.
Active Ingredient/Synonyms
Bordetella pertussis filamentous hemagglutinin vaccine, inactivated | Filamentous haemagglutinin | Filamentous haemagglutinin adsorbed | Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) |
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.
Description
Bordetella pertussis pertactin antigen is a vaccine for the prophylaxis of whooping cough that contains pertactin, a membrane-associated antigen of Bordetella pertussis [A31248].
Active Ingredient/Synonyms
Bordetella pertussis pertactin vaccine, inactivated | Pertactin | Pertactin adsorbed | Bordetella pertussis pertactin antigen |
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.
Description
Clostridium tetani toxoid antigen (formaldehyde inactivated) is a vaccine for intramuscular injection. It is used for active immunization of children 7 years of age or older, and adults, for prevention of tetanus. The toxoid in the Clostridium tetani culture is grown and detoxified followed by purification via ammonium sulfate filtration and precipation.
Active Ingredient/Synonyms
Tetanus toxoid | Tetanus toxoid adsorbed | tetanus toxoid vaccine, inactivated | Clostridium tetani toxoid antigen (formaldehyde inactivated) |
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.